Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...

For nearly a decade, Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. Now, with its business booming, the company is setting up a similar site 10 hours to the ...

Jan 13 (Reuters) - (This Jan. 13 story has been corrected to say 'drugmakers will ask,' not 'Eli Lilly has asked' to pause negotiations, after the company clarified, in the headline & paragraph 1 ...

SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start ...

Shares of Eli Lilly & Co. dropped over 7% on Tuesday morning, reaching levels last seen in late November and marking the ...

Earnings Report 5.405 USD Q4 2024 Earnings Release 02/06/2025 Earnings Report 4.972 USD Q1 2025 Earnings Release 05/01/2025 Earnings Report 5.790 USD Q2 2025 Earnings Release 08/07/2025 Earnings ...

Influencer Lilly-Ella Gerard shared a picture of scans with her 216,000 Instagram followers before her legendary father replied: “We can’t wait. Great news and congratulations we love you.” ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Eli Lilly has struck a $2.4 billion deal to buy Dice Therapeutics and its drug discovery and development platform for oral, small molecule therapies for immunological diseases. The big pharma is ...

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim ... and cardiovascular death in people with chronic kidney disease (CKD). The new indication could unlock a sizeable ...